Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958316 · ClinicalTrials.gov registry record · NA
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
A NA study of Cancer and Childhood Cancer, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 4
- Study locations
NCT05958316: Recruiting NA study of Cancer and Childhood Cancer, sponsored by Virginia Commonwealth University.
NCT05958316 is a NA study of Cancer and Childhood Cancer that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 126 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05958316, a NA study of Cancer and Childhood Cancer, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 4
- Study locations
Study Summary
Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
Primary Outcome
Self-efficacy for symptom management will be assessed with the PROMIS® Self Efficacy for Symptom Management Scale that contains 28 items and assess the person's current level of confidence to manage/control symptoms, manage symptoms in different settings, and keep symptoms from interfering with work, relationships, or activities. Response options are on a 5-point Likert scale (1=I am not confident at all; 5=I am very confident). Scores are summed across items, and higher scores indicate greater
Conditions Studied
Interventions
- BEHAVIORAL Usual Care Control
- BEHAVIORAL Computerized Symptom Capture Tool (C-SCAT) Intervention
Study Locations (4)
Missouri
- Children's Mercy Hospital - Kansas City
Utah
- University of Utah Primary Children's Hospital - Salt Lake City
Virginia
- Virginia Commonwealth University - Richmond
Washington
- Seattle Children's Hospital @ University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05958316 shows while recruiting
NCT05958316 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Control is the first listed.
NCT05958316 reports a single indexed study location in Missouri, Utah, Virginia.
Frequently Asked Questions
What is clinical trial NCT05958316 about?
NCT05958316 is a clinical study titled "Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer". Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
What is the current status of trial NCT05958316?
This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-01-04. Estimated completion is 2026-08-31.
What conditions does trial NCT05958316 study?
This clinical trial studies the following conditions: Cancer, Childhood Cancer, Symptoms and Signs.
What interventions are being tested in trial NCT05958316?
The interventions under investigation include: Usual Care Control (BEHAVIORAL), Computerized Symptom Capture Tool (C-SCAT) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05958316?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05958316 being conducted?
This trial has 4 study locations across Missouri, Utah, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05958316's enrollment target sits among peer trials
126 282nd of 615 higher than 331 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI